Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
giuseppe.cimino@uniroma1.it
Giuseppe Cimino
Professore Associato
Struttura:
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
E-mail:
giuseppe.cimino@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
‘Real Life’ experience in a ‘difficult to treat’ patient population of non-Hodgkin lymphomas using the R-COMP regimen
LEUKEMIA & LYMPHOMA
2016
Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients
AMERICAN JOURNAL OF HEMATOLOGY
2016
Essential Thrombocythemia: A Comparison of Overall and Thrombosis Free Survival in Two Discrete Periods of the First Decade of 2000. a Retrospective Analysis
BLOOD
2016
Do malignant diseases affect semen quality? Sperm parameters of men with cancers
ANDROLOGIA
2016
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
LEUKEMIA
2015
A Genotypic-oriented View of CFTR Genetics Highlights Specific Mutational Patterns Underlying Clinical Macro-categories of Cystic Fibrosis.
MOLECULAR MEDICINE
2015
Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells
CANCER RESEARCH
2015
Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease
JOURNAL OF PAIN RESEARCH
2015
Are ET and PV Patients Two Similar Populations As Concern Thrombotic Risk Factors?
BLOOD
2015
Application of the International Prognostic Score of Thrombosis for Essential Thrombocytemia(ET) (IPSET-Thrombosis) in a Cohort of ET Patients: Experience from Gruppo Laziale for Myeloproliferative Ph Negative Neoplasms
BLOOD
2015
The Platelet COUNT at Diagnosis of Essential Thrombocythemia Is a Prognostic Factor for Thrombosis-Free Survival: Retrospective Analysis on 1201 Patients
BLOOD
2015
ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA
HAEMATOLOGICA
2015
SPLEEN ENLARGEMENT IS A RISK FACTOR FOR THROMBOSIS IN ESSENTIAL THROMBOCYTHEMIA: EVALUATION ON 1097 PATIENTS AND VALIDATION ON 792 PATIENTS
HAEMATOLOGICA
2015
ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA
HAEMATOLOGICA
2015
Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.
ANNALS OF HEMATOLOGY
2015
Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis
LEUKEMIA RESEARCH
2015
« prima
< precedente
1
2
3
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma